Nose to brain delivery of selegiline loaded PLGA/lipid nanoparticles : Synthesis, characterisation and brain pharmacokinetics evaluation
Parkinson's disease (PD) is the second most common progressive neurodegenerative disease that promotes neuronal cell death. The primary treatment strategy for Parkinson's disease involves the therapy of an MAO-B inhibitor molecule, selegiline. The present research aims to fabricate selegil...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | en en |
| Published: |
Editions de Sante
2022
|
| Subjects: | |
| Online Access: | http://umpir.ump.edu.my/id/eprint/40195/1/Nose%20to%20brain%20delivery%20of%20selegiline%20loaded%20PLGA.pdf http://umpir.ump.edu.my/id/eprint/40195/2/Nose%20to%20brain%20delivery%20of%20selegiline%20loaded%20PLGA_lipid%20nanoparticles_Synthesis%2C%20characterisation%20and%20brain%20pharmacokinetics%20evaluation_ABS.pdf http://umpir.ump.edu.my/id/eprint/40195/ https://doi.org/10.1016/j.jddst.2022.103923 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Internet
http://umpir.ump.edu.my/id/eprint/40195/1/Nose%20to%20brain%20delivery%20of%20selegiline%20loaded%20PLGA.pdfhttp://umpir.ump.edu.my/id/eprint/40195/2/Nose%20to%20brain%20delivery%20of%20selegiline%20loaded%20PLGA_lipid%20nanoparticles_Synthesis%2C%20characterisation%20and%20brain%20pharmacokinetics%20evaluation_ABS.pdf
http://umpir.ump.edu.my/id/eprint/40195/
https://doi.org/10.1016/j.jddst.2022.103923
